Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gamma-aminobutyric acid type B receptor subunit 2 (GABBR2) is a protein that forms part of the GABA_B receptor, a member of the class C family of G protein-coupled receptors (GPCRs). The functional GABA_B receptor is an obligate heterodimer composed of GABBR1 and GABBR2. GABBR2 does not bind agonists directly but is essential for coupling ligand binding to downstream intracellular signaling pathways via interaction with guanine nucleotide-binding proteins (G-proteins). It mediates inhibitory neurotransmission in the central nervous system.
Forms obligate heterodimer with GABBR1; GABBR2 mediates coupling to G proteins and downstream signaling, including potassium channel activation, inhibition of adenylyl cyclase, and inhibition of calcium channels.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type B receptor subunit 2 (GABBR2).